全文获取类型
收费全文 | 28880篇 |
免费 | 1871篇 |
国内免费 | 91篇 |
专业分类
耳鼻咽喉 | 436篇 |
儿科学 | 1317篇 |
妇产科学 | 729篇 |
基础医学 | 3035篇 |
口腔科学 | 507篇 |
临床医学 | 2634篇 |
内科学 | 6620篇 |
皮肤病学 | 526篇 |
神经病学 | 1953篇 |
特种医学 | 986篇 |
外科学 | 4522篇 |
综合类 | 521篇 |
一般理论 | 4篇 |
预防医学 | 1846篇 |
眼科学 | 1022篇 |
药学 | 2100篇 |
1篇 | |
中国医学 | 112篇 |
肿瘤学 | 1971篇 |
出版年
2023年 | 260篇 |
2022年 | 544篇 |
2021年 | 1129篇 |
2020年 | 651篇 |
2019年 | 863篇 |
2018年 | 999篇 |
2017年 | 706篇 |
2016年 | 772篇 |
2015年 | 825篇 |
2014年 | 1148篇 |
2013年 | 1486篇 |
2012年 | 2208篇 |
2011年 | 2083篇 |
2010年 | 1260篇 |
2009年 | 1030篇 |
2008年 | 1564篇 |
2007年 | 1518篇 |
2006年 | 1429篇 |
2005年 | 1353篇 |
2004年 | 1187篇 |
2003年 | 1018篇 |
2002年 | 935篇 |
2001年 | 523篇 |
2000年 | 543篇 |
1999年 | 439篇 |
1998年 | 230篇 |
1997年 | 180篇 |
1996年 | 152篇 |
1995年 | 148篇 |
1994年 | 137篇 |
1993年 | 103篇 |
1992年 | 294篇 |
1991年 | 263篇 |
1990年 | 232篇 |
1989年 | 225篇 |
1988年 | 190篇 |
1987年 | 185篇 |
1986年 | 161篇 |
1985年 | 176篇 |
1984年 | 162篇 |
1983年 | 153篇 |
1982年 | 84篇 |
1981年 | 81篇 |
1980年 | 70篇 |
1979年 | 121篇 |
1978年 | 97篇 |
1974年 | 77篇 |
1973年 | 114篇 |
1972年 | 105篇 |
1971年 | 71篇 |
排序方式: 共有10000条查询结果,搜索用时 11 毫秒
21.
P M Doraiswamy K R Krishnan O B Boyko M M Husain G S Figiel V J Palese P R Escalona S A Shah W M McDonald W J Rockwell 《Progress in neuro-psychopharmacology & biological psychiatry》1991,15(3):351-356
1. The frequent occurrence of hypothalamo-pituitary dysfunction in patients with eating disorders as well as prior reports that nutritional and endocrine status influence pituitary morphology, led us to hypothesize that pituitary size and shape may be altered in patients with eating disorders. 2. Magnetic resonance imaging (MRI) does not use ionizing radiation and is currently one of the most feasible modalities available to study the pituitary gland in vivo. Using MRI, we have previously reported in a preliminary study that female patients with eating disorders had significantly smaller pituitary glands than controls. In addition MRI excluded any pituitary mass lesions. 3. In this report, we confirm our previous MRI findings and provide further evidence of pituitary abnormalities in an expanded sample of eating disorder patients. Preliminary data on pituitary volume estimates from MRI scans are provided for a subset of patients and controls. 相似文献
22.
23.
Bradley J Catalone Shendra R Miller Mary Lee Ferguson Dan Malamud Tina Kish-Catalone Nina J Thakkar Fred C Krebs Mary K Howett Brian Wigdahl 《Biomedicine & Pharmacotherapy》2005,59(8):430-437
C31G, which has potent activity against the human immunodeficiency virus type 1 (HIV-1) and an established record of safety in animal studies and human trials, is a microbicidal agent comprised of a buffered equimolar mixture of two amphoteric, surface-active agents: an alkyl amine oxide (C14AO) and an alkyl betaine (C16B). Studies of long-term in vitro exposure to C31G and its constituents have suggested that the components of C31G may contribute differentially to its toxicity and efficacy. In the present studies, in vitro assays of cytotoxicity and anti-HIV-1 activity demonstrated that C16B was slightly less cytotoxic compared to either C31G or C14AO, whereas the anti-HIV-1 activities of C31G and its individual constituents were similar. In the murine model of cervicovaginal microbicide toxicity, in vivo exposure to C14AO resulted in severe cervical inflammation followed by a delayed disruption of the columnar epithelium. In contrast, exposure to C16B caused severe cervical epithelial disruption and a secondary, less intense inflammatory response. These results demonstrate that (i) there are both mechanistic and temporal differences in toxicity associated with the components of C31G not necessarily predicted by in vitro assessments of cytotoxicity and (ii) contributions of each component to the anti-HIV-1 activity of C31G appear to be equal. In addition, these findings indicate that direct and indirect mechanisms of in vivo toxicity can be observed as separate but interrelated events. These results provide further insight into the activity of C31G, as well as mechanisms potentially associated with microbicide toxicity. 相似文献
24.
25.
Ramshekhar N. Menon Nirav Sanghani Mahendra Javali Neeraj Jain Arun B. Shah 《Annals of Indian Academy of Neurology》2009,12(1):40-44
We report an unusual case of sporadic adult onset cerebellar ataxia with hypogonadism. A 40-year-old unmarried man presented with progressive ataxia and dysarthria along with complaints of non-development of secondary sexual characteristics and erectile dysfunction. There were complaints of intermittent diarrhea. Clinical examination revealed a pan-cerebellar syndrome with features of hypoandrogenism. No eye movement abnormalities were evident. There were signs of malabsorption. Investigations confirmed the presence of auto-antibodies found in celiac disease, and a duodenal biopsy confirmed the same. Hypoandrogenism was postulated to be due to hypergonadotropic hypogonadism which has been mentioned in a few patients of celiac disease. However, the pattern seen in our patient was of a hypogonadotropic hypogonadism. This is probably secondary to an autoimmune hypophysitis seen in some patients in the absence of other clinical manifestations. Autoantibody testing should be a diagnostic necessity in any adult with a sporadic cerebellar ataxia. 相似文献
26.
Heiko Sch?der Diane L Carlson Dennis H Kraus Hilda E Stambuk Mithat G?nen Yusuf E Erdi Henry W D Yeung Andrew G Huvos Jatin P Shah Steven M Larson Richard J Wong 《Journal of nuclear medicine》2006,47(5):755-762
(18)F-FDG PET has a high accuracy in staging head and neck cancer, but its role in patients with clinically and radiographically negative necks (N0) is less clear. In particular, the value of combined PET/CT has not been determined in this group of patients. METHODS: In a prospective study, 31 patients with oral cancer and no evidence of lymph node metastases by clinical examination or CT/MRI underwent (18)F-FDG PET/CT before elective neck dissection. PET/CT findings were recorded by neck side (left or right) and lymph node level. PET/CT findings were compared with histopathology of dissected nodes, which was the standard of reference. RESULTS: Elective neck dissections (26 unilateral, 5 bilateral; a total of 36 neck sides), involving 142 nodal levels, were performed. Only 13 of 765 dissected lymph nodes harbored metastases. Histopathology revealed nodal metastases in 9 of 36 neck sides and 9 of 142 nodal levels. PET was TP in 6 nodal levels (6 neck sides), false-negative in 3 levels (3 neck sides), true-negative in 127 levels (23 neck sides), and false-positive in 6 levels (4 neck sides). The 3 false-negative findings occurred in metastases smaller than 3 mm or because of inability to distinguish between primary tumor and adjacent metastasis. TP and false-positive nodes exhibited similar standardized uptakes (4.8 +/- 1.1 vs. 4.2 +/- 1.0; P = not significant). Sensitivity and specificity were 67% and 85% on the basis of neck sides and 67% and 95% on the basis of number of nodal levels, respectively. If a decision regarding the need for neck dissection had been based solely on PET/CT, 3 false-negative necks would have been undertreated, and 4 false-positive necks would have been overtreated. CONCLUSION: (18)F-FDG PET/CT can identify lymph node metastases in a segment of patients with oral cancer and N0 neck. A negative test can exclude metastatic deposits with high specificity. Despite reasonably high overall accuracy, however, the clinical application of PET/CT in the N0 neck may be limited by the combination of limited sensitivity for small metastatic deposits and a relatively high number of false-positive findings. The surgical management of the N0 neck should therefore not be based on PET/CT findings alone. 相似文献
27.
目的观察JAK2激酶抑制剂AG490对结肠癌HT-29细胞侵袭以及对基质金属蛋白酶-2(MMP-2)表达的影响,探讨STAT3信号转导通路在结肠癌侵袭转移调控中的作用。方法应用JAK2激酶抑制剂AG490处理结肠癌HT-29细胞,Matrigel肿瘤体外侵袭模型检测肿瘤细胞侵袭;Western blot检测STAT3蛋白表达;逆转录-聚合酶链反应(RT—PCR)检测MMP2mRNA表达。结果AG490可抑制JAK2/STAT3信号转导通路活化及结肠癌HT-29细胞侵袭,在此过程中AG490在mRNA水平抑制MMP-2表达。结论STAT3信号转导通路参与结肠癌细胞侵袭调控,阻断STAT3通路活化可抑制结肠癌细胞侵袭,这一作用可能是通过抑制MMP-2表达实现的。 相似文献
28.
Practical management of patients with non-small-cell lung cancer treated with gefitinib. 总被引:7,自引:0,他引:7
Neelam T Shah Mark G Kris William Pao Leslie B Tyson Barbara M Pizzo Murk-Hein Heinemann Leah Ben-Porat Dana L Sachs Robert T Heelan Vincent A Miller 《Journal of clinical oncology》2005,23(1):165-174
PURPOSE: The use of gefitinib, the first drug approved to inhibit the epidermal growth factor receptor tyrosine kinase, is indicated in patients with non-small-cell lung cancer with tumors progressive after chemotherapy. The unique mechanism of action of this agent leads to distinctive patterns of response and toxicity in persons with lung cancer. Many of the principles of management relevant to gefitinib are distinct from those with conventional cytotoxic drugs. To meet this need, we present practical guidelines on the use of gefitinib in patients with non-small-cell lung cancer. METHODS: This article reviews gefitinib's indications, dosing, response phenomena, and patterns of relapse in individuals with radiographic response. RESULTS: We present our recommendations for the management of rash and diarrhea caused by this agent. CONCLUSION: This information can guide practitioners and help them inform their patients about what to expect when they receive gefitinib. 相似文献
29.
30.
M J D Wagstaff M Shah D A McGrouther D S Latchman 《Journal of plastic, reconstructive & aesthetic surgery》2007,60(9):974-982
Heat shock proteins are diverse and essential components of cell physiology. Their expression is elevated in the cell undergoing stress, where they protect the cell from death by necrosis or apoptosis and accelerate recovery. Significant advances have been made in studies relevant to plastic surgery regarding these proteins and their manipulation. This review introduces the heat shock proteins and appraises these studies in skin, ultraviolet light exposure, neoplasia, wound healing, ageing, burns, and reconstructive surgery. 相似文献